Posted by Michael Wonder on 06 May 2019
PHARMAC Chairman backs early access scheme for new drugs
7 May 2019 - PHARMAC board chairman Steve Maharey is backing an early access scheme that would give patients access to new and emerging drugs faster.
Maharey told the Herald that while PHARMAC's core business was sound, it was a model under stress.
Pharmaceuticals and medical devices were changing with increasing speed and the migration of new ideas around the world was much faster, Maharey said.
